Subthalamic deep brain stimulation in a case of idiopathic Parkinson's disease and schizophrenia

Parkinson's disease (PD) and schizophrenia can coexist. Antipsychotics block striatal D2 receptors, which inevitably aggravates the manifestations of PD. We report the case of a male patient with idiopathic Parkinson's disease and schizophrenia, with poor tolerance to minimal doses of levo...

Full description

Saved in:
Bibliographic Details
Published in:Revista de neurologiá 2023-10, Vol.77 (7), p.167
Main Authors: Fernández-Pajarín, G, Ares-Pensado, B, Koukoulis, A, Jiménez-Martín, I, Sesar, A
Format: Article
Language:Spanish
Subjects:
Antipsychotic Agents - therapeutic use
Deep Brain Stimulation
Humans
Levodopa - therapeutic use
Male
Parkinson Disease - complications
Parkinson Disease - therapy
Schizophrenia - complications
Schizophrenia - therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Parkinson's disease (PD) and schizophrenia can coexist. Antipsychotics block striatal D2 receptors, which inevitably aggravates the manifestations of PD. We report the case of a male patient with idiopathic Parkinson's disease and schizophrenia, with poor tolerance to minimal doses of levodopa, who underwent a dramatic improvement after bilateral subthalamic deep brain stimulation (DBS-STN). DBS-STN was taken into consideration here, due to the severity of this particular case, as the only possible way to achieve motor improvement. The diagnosis of idiopathic PD was confirmed despite antidopaminergic treatment. DBS-STN can be considered a treatment option for disabling manifestations of PD, provided that a careful selection of patients is carried out..
ISSN:1576-6578